المؤلفون: Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić

المصدر: Translational Oncology, Vol 38, Iss , Pp 101799- (2023)

مصطلحات موضوعية: Metastatic melanoma patients, BRAF wild type, Pembrolizumab, Cytokines, Monitoring, Outcome predictors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S1936523323001857Test; https://doaj.org/toc/1936-5233Test

الوصول الحر: https://doaj.org/article/c68b01a901b24440bc1d7b0973b2c6f9Test

المؤلفون: Tolcher, Anthony W, Kurzrock, Razelle, Valero, Vincente, Gonzalez, Rene, Heist, Rebecca S, Tan, Antoinette R, Means-Powell, Julie, Werner, Theresa L, Becerra, Carlos, Wang, Chenxi, Leonowens, Cathrine, Kalyana-Sundaram, Shanker, Kleha, Joseph F, Gauvin, Jennifer, D’Amelio, Anthony M, Ellis, Catherine, Ibrahim, Nageatte, Yan, Li

المصدر: Cancer Chemotherapy and Pharmacology. 85(4)

مصطلحات موضوعية: Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Clinical Research, Cancer, Evaluation of treatments and therapeutic interventions, 6.2 Cellular and gene therapies, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Cohort Studies, Diamines, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Male, Maximum Tolerated Dose, Melanoma, Middle Aged, Prognosis, Proto-Oncogene Proteins c-akt, Pyrazoles, Pyridones, Pyrimidinones, Tissue Distribution, Triple Negative Breast Neoplasms, Young Adult, AKT inhibitor, BRAF-wild type melanoma, MEK inhibitor, Trametinib, Triple-negative breast cancer, Uprosertib, Oncology & Carcinogenesis, Oncology and carcinogenesis, Pharmacology and pharmaceutical sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6c2779pgTest

المؤلفون: Lisa Salvatore, Maria Bensi, Raffaella Vivolo, Ina Valeria Zurlo, Emanuela Dell’Aquila, Roberta Grande, Annunziato Anghelone, Alessandra Emiliani, Fabrizio Citarella, Maria Alessandra Calegari, Marta Ribelli, Michele Basso, Carmelo Pozzo, Giampaolo Tortora

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: colorectal cancer, primary tumor site, third-line therapy, RAS/BRAF wild-type, anti-egfr ab, Regorafenib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2023.1125013/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/86c077691eb844e5b6aadfff0bfac739Test

المؤلفون: Annabel H. S. Alig, Volker Heinemann, Michael Geissler, Ludwig Fischer von Weikersthal, Thomas Decker, Kathrin Heinrich, Swantje Held, Lena Weiss, Laura E. Fischer, Nicolas Moosmann, Arndt Stahler, Ivan Jelas, Annika Kurreck, Jobst C. von Einem, Anke C. Reinacher-Schick, Andrea Tannapfel, Clemens Giessen-Jung, Sebastian Stintzing, Dominik P. Modest

المصدر: Cancers; Volume 14; Issue 3; Pages: 526

مصطلحات موضوعية: anti-EGFR antibody, metastatic colorectal cancer, primary tumor location, RAS/BRAF wild-type

وصف الملف: application/pdf

العلاقة: Cancer Therapy; https://dx.doi.org/10.3390/cancers14030526Test

الإتاحة: https://doi.org/10.3390/cancers14030526Test

المؤلفون: Salvatore, Lisa, Bensi, Maria, Vivolo, Raffaella, Zurlo, Ina Valeria, Dell'Aquila, Emanuela, Grande, Roberta, Anghelone, Annunziato, Emiliani, Alessandra, Citarella, Fabrizio, Calegari, Maria Alessandra, Ribelli, Marta, Basso, Michele, Pozzo, Carmelo, Tortora, Giampaolo

المصدر: Frontiers in Oncology. 13

مصطلحات موضوعية: Regorafenib, Cancer Research, third-line therapy, Settore MED/06 - ONCOLOGIA MEDICA, Oncology, RAS/BRAF wild-type, colorectal cancer, primary tumor site, anti-egfr ab, trifluridine/tipiracil

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f302fb485572aebd5b86746944a5132Test
https://doi.org/10.3389/fonc.2023.1125013Test

المؤلفون: Francesco Masedu, Marco Clementi, Odysseas Zoras, Donatella Sarti, Konstantinos Lasithiotakis, Giammaria Fiorentini, Andrew R. Mackay, Antonietta R. Farina, Stefano Guadagni

المصدر: Journal of Surgical Research. 268:737-747

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, Melphalan, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Recurrent melanoma, BRAF wild-type, Hyperthermic isolated limb perfusion, medicine, Limb perfusion, Clinical endpoint, Humans, Infusions, Intra-Arterial, Stage IIIC, Prospective Studies, Prospective cohort study, Melanoma, Pelvis, Chemotherapy, business.industry, Hypoxic pelvic and limb perfusion, Extremities, medicine.disease, medicine.anatomical_structure, Locoregional metastases, Chemotherapy, Cancer, Regional Perfusion, Locoregional metastases, Hyperthermic isolated limb perfusion, Isolated limb infusion, Hypoxic pelvic and limb perfusion, Novel immunotherapies, Surgery, Radiology, Isolated limb infusion, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6414f396a72756ddc246001c3fb53b99Test
https://doi.org/10.1016/j.jss.2021.05.054Test

المؤلفون: Jin Peng, Qingfeng Zhang, Fei Lin, Chao Ke, Wuguo Deng, Ankui Yang, Xuan Su

مصطلحات موضوعية: Epigenetics (incl. genome methylation and epigenomics), BRAF wild-type, DNA methylation marker, epigenetic signature, GRIK2, metastasis, thyroid carcinoma

العلاقة: https://figshare.com/articles/dataset/Epigenetic_signature_discriminates_lymphatic_metastasis_in_i_BRAF_i_wild-type_thyroid_carcinoma_methylation_role_of_i_GRIK2_i_/24610011Test

الإتاحة: https://doi.org/10.25402/epi.24610011.v1Test
https://figshare.com/articles/dataset/Epigenetic_signature_discriminates_lymphatic_metastasis_in_i_BRAF_i_wild-type_thyroid_carcinoma_methylation_role_of_i_GRIK2_i_/24610011Test

المؤلفون: Sharon Love, Pippa Corrie, S B Mohammed, V. Urbonas, M Goff, Claire Scudder, Matthew Wheater, Dirk Schadendorf, Elizabeth Ruth Plummer, Cornelia Mauch, Lisa Zimmer, Mark R. Middleton, Ernie Marshall, Sarah Danson

المصدر: Annals of Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_treatment, Medizin, Phases of clinical research, BRAF wild-type, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, pazopanib, Melanoma, Aged, 80 and over, Trametinib, Sulfonamides, trametinib, Hematology, Middle Aged, phase II, Prognosis, Chemotherapy regimen, Survival Rate, Paclitaxel, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Indazoles, Pyridones, Pyrimidinones, Pazopanib, 03 medical and health sciences, Internal medicine, medicine, Humans, neoplasms, Aged, Chemotherapy, business.industry, Original Articles, medicine.disease, 030104 developmental biology, Pyrimidines, chemistry, Mutation, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::693c356d08bf1e1bf51c5f631c6e1644Test
http://europepmc.org/articles/PMC6386028Test

المؤلفون: Daniil Stroyakovskiy, Yu Guo, Isabelle Rooney, P. Francesco Ferrucci, Keith T. Flaherty, Zeynep Eroglu, Jacopo Pigozzo, S. Troutman, Jacek Mackiewicz, S. Mulla, Athina Voulgari, Piotr Rutkowski, Bethany Pitcher, Brigitte Dréno, Lev V. Demidov, J.M.G. Larkin, A. Arance, M. Castro, Helen Gogas, Yibing Yan

المساهمون: National and Kapodistrian University of Athens (NKUA), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Royal Marsden NHS Foundation Trust, N.N. Blokhin Russian Cancer Research Center, Moscow City Oncology Hospital No. 62 [Moscow, Russia] (MCOH), H. Lee Moffitt Cancer Center and Research Institute, European Institute of Oncology [Milan] (ESMO), Veneto Institute of Oncology IOV-IRCCS [Padua, Italy], Maria Sklodowska-Curie National Research Institute of Oncology [Krakow, Poland], Poznan University of Medical Sciences [Poland] (PUMS), Genentech, Inc. [San Francisco], Roche Products Ltd, F. Hoffmann-La Roche [Basel], Massachusetts General Hospital Cancer Center [Boston, MA, USA], Harvard Medical School [Boston] (HMS), Hospital Clinic [Barcelona, Spain], Malbec, Odile

المصدر: Annals of Oncology
Annals of Oncology, 2020, 32 (3), pp.384-394. ⟨10.1016/j.annonc.2020.12.004⟩

مصطلحات موضوعية: 0301 basic medicine, atezolizumab, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Population, Pembrolizumab, Gastroenterology, BRAF wild-type, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Atezolizumab, Interquartile range, Internal medicine, medicine, melanoma, education, Adverse effect, cobimetinib, Cobimetinib, education.field_of_study, business.industry, Hazard ratio, Hematology, Rash, [SDV] Life Sciences [q-bio], 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, pembrolizumab, medicine.symptom, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bd6e100134121fbd8dbf0a9bbc3280Test
https://www.hal.inserm.fr/inserm-03710214Test

المؤلفون: Vivolo R, Bria E, Zurlo IV, Bensi M, Dell'Aquila E, Anghelone A, Corsi DC, Caira G, Santini D, Ingrosso D, Emiliani A, Calegari MA, Citarella F, Pozzo C, Grande R, Basso M, Tortora G, Salvatore L

المساهمون: Vivolo, R, Bria, E, Zurlo, Iv, Bensi, M, Dell'Aquila, E, Anghelone, A, Corsi, Dc, Caira, G, Santini, D, Ingrosso, D, Emiliani, A, Calegari, Ma, Citarella, F, Pozzo, C, Grande, R, Basso, M, Tortora, G, Salvatore, L

مصطلحات موضوعية: RAS/BRAF wild-type, Regorafenib, anti-egfr ab, colorectal cancer, primary tumor site, third-line therapy, trifluridine/tipiracil

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000560368302092; volume:38; issue:15; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11573/1642369Test

الإتاحة: https://hdl.handle.net/11573/1642369Test